IP Library › Granted Patent US 8,383,372
Granted Patent B2
US 8,383,372 · App. 12/397,683 · Granted Feb 26, 2013

L-cysteine producing bacterium and a method for producing L-cysteine

Inventors: Gen Nonaka (Kawasaki, JP); Kazuhiro Takumi (Kawasaki, JP)
Assignee: Ajinomoto Co., Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,383,372
App. No.
12/397,683
Granted
Feb 26, 2013
Kind
B2
Abstract

The present invention describes a bacterium belonging to the family Enterobacteriaceae which has L-cysteine-producing ability and has been modified to decrease the activity of a protein encoded by the d0191 gene. This bacterium is cultured in a medium, and L-cysteine, L-cystine, derivatives thereof, or a mixture thereof is collected from the medium.

Claims (12)

1. A method for producing an L-amino acid selected from the group consisting of L-cysteine, L-cystine, derivatives thereof, and combinations thereof, which comprises culturing a bacterium belonging to the family Enterobacteriaceae in a medium and collecting the L-amino acid from the medium,

wherein the bacterium has L-cysteine-producing ability and has been modified to decrease the activity of a protein selected from the group consisting of:

(A) a protein comprising the amino acid sequence of SEQ ID NO:2, and

(B) a protein comprising the amino acid sequence of SEQ ID NO:2 but which includes substitutions, deletions, insertions, or additions of 1 to 10 amino acid residues, and wherein said protein comprises cysteine desulfhydrase activity.

2. The method according to claim 1 , wherein the derivative of L-cysteine is a thiazolidine derivative.

3. The method according to claim 1 , wherein the activity of the protein is decreased by a method selected from the group consisting of decreasing the expression of a gene encoding the protein, and by disrupting the gene encoding the protein.

4. The method according to claim 1 , wherein the protein is encoded by a gene selected from the group consisting of:

(a) a DNA comprising the nucleotide sequence of SEQ ID NO:1, and

(b) a DNA which is able to hybridize with a sequence complementary to the nucleotide sequence of SEQ ID NO:1under stringent conditions comprising washing at 60° C., 0.1×SSC, 0.1% SDS, and encodes a protein comprising cysteine desulfhydrase activity.

5. The method according to claim 1 , wherein the bacterium further comprises a serine acetyltransferase which has been mutated so that feedback inhibition by L-cysteine is attenuated.

6. The method according to claim 1 , wherein the bacterium is a Pantoea bacterium.

7. The method according to claim 6 , wherein the bacterium is Pantoea ananatis .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2009
From: NONAKA, GEN; TAKUMI, KAZUHIRO
To: AJINOMOTO CO., INC.
Reel/Frame 022647/0590 →
Priority Claims (1)
JP 2008-056371 · Mar 6, 2008 · national
Continuity (1)
Related Publication 20090226984A1 · Sep 10, 2009